Recent studies have strongly shown that cell-to-cell transmission of neuropathogenic proteins is a common mechanism for the development of neurodegenerative diseases. However, the underlying cause is complex and little is known. Although distinct processes are involved in the pathogenesis of various diseases, they all share the common feature of iron accumulation, an attribute that is particularly prominent in synucleinopathies. However, whether iron is a cofactor in facilitating the spread of a-synuclein remains unclear. Here, we constructed a cell-to-cell transmission model of a-synuclein using SN4741 cell line based on adenovirus vectors. Cells were treated with FeCl 2, and a-synuclein aggregation and transmission were then evaluated. In addition, the possible mechanisms were investigated through gene knockdown or over-expression. Our results demonstrated that iron promoted a-synuclein aggregation and transmission by inhibiting autophagosome-lysosome fusion. Furthermore, iron decreased the expression of nuclear transcription factor EB (TFEB), a master transcriptional regulator of autophagosome-lysosome fusion, and inhibited its nuclear translocation through activating AKT/mTORC1 signaling. After silencing TFEB, ratios of asynuclein aggregation and transmission were not significantly altered by the presence of iron; on the other hand, when TFEB was over-expressed, the transmission of a-synuclein induced by iron was obviously reversed; suggesting the mechanism by which iron promotes a-synuclein transmission may be mediated by TFEB. Taken together, our data reveal a previously unknown relationship between iron and a-synuclein, and identify TFEB as not only a potential target for preventing a-synuclein transmission, but also a critical factor for iron-induced a-synuclein aggregation and transmission. Indeed, this newly discovered role of iron and TFEB in synucleinopathies may provide novel targets for developing therapeutic strategies to prevent a-synuclein transmission in Parkinson's disease.
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Introduction
Parkinson's disease (PD) is the second most common neurodegenerative disorder after Alzheimer's disease, and is characterized by resting tremor, muscular rigidity, bradykinesia, and postural and gait imbalance (Ascherio and Schwarzschild 2016) , affecting 1-2% of people aged 65 years or greater worldwide (Lewis et al. 2016) . The primary neuropathological hallmark of PD is the presence of a-synuclein-positive Lewy body (Spillantini et al. 1997) . Although many studies have shown a-synuclein aggregation to be an important cause in the onset and progression of PD, exact pathological mechanisms remain largely unknown (Vekrellis et al. 2011; Bendor et al. 2013; Kahle et al. 2015; Wong and Krainc 2017) .
Recent studies have suggested a prion-like effect of asynuclein, as it can be transmitted from one cell to another (Kordower et al. 2008; Li et al. 2008; Hansen et al. 2011; Luk et al. 2012) . Subsequent studies have identified similar prion-like mechanisms of other neuropathogenic proteins, such as tau and amyloid b in Alzheimer's disease (Nath et al. 2012; Mohamed et al. 2013) , Transactive response (TAR) DNA-binding protein 43 in amyotrophic lateral sclerosis (Nonaka et al. 2013) , and mutant huntingtin in Huntington's disease (Pecho-Vrieseling et al. 2014) . While these results suggest that mechanisms of neuropathogenic protein propagation in these diseases may be similar to prion pathogenesis, it is unclear whether a common factor promotes propagation of these misfolded proteins. If such an important contributing factor can be identified and verified, it will facilitate new therapeutic strategies to prevent the transmission of misfolded proteins associated with neurodegenerative disorders.
Iron accumulation has been implicated in the pathogenesis of various neurodegenerative disorders, including PD, Alzheimer's disease, amyotrophic lateral sclerosis and Huntington's disease (Oshiro et al. 2011; Muller and Leavitt 2014; Belaidi and Bush 2016; Gajowiak et al. 2016) . Moreover, iron accumulation has been consistently observed in prion disorder (Singh et al. 2009 Singh 2014) .
Although distinct processes are involved in the pathogenesis of neurodegenerative and prion disorders, both share the common feature of iron accumulation. This led us to propose iron accumulation as a cofactor in facilitating propagation of neuropathogenic and prion proteins. As a-synuclein is transmitted more easily than other neuropathogenic proteins (Ugalde et al. 2016 ) and iron accumulation is particularly prominent in synucleinopathies (Snyder and Connor 2009; Jiang et al. 2016) , we investigated the relationship between iron and a-synuclein transmission to examine a potentially unified pathogenic mechanism involving iron and other neuropathogenic proteins.
Lysosomal dysfunction is another shared feature contributing to many neurodegenerative disorders (Boyd and Valenzano 2014; Fraldi et al. 2016) . Previous researches demonstrating enhanced a-synuclein aggregation and transmission with deficiency of either b-glucocerebrosidase 1 or cathepsin D (both lysosomal protein hydrolases) (Bae et al. 2014 (Bae et al. , 2015 , suggest that normal lysosomal function is important for clearance of aggregated a-synuclein and inhibition of its propagation. Iron accumulation leads to the deposition of large amounts of iron within lysosomes (Terman and Kurz 2013) . As a result, high levels of iron-catalyzed Fenton reaction damage lysosomal membrane integrity (Kurz et al. 2011; Terman and Kurz 2013) . However, the lysosomal degradation pathway depends on the formation of autophagosome-lysosomes (Manzoni and Lewis 2013) . It is notable that recent studies have shown that the transcription factor EB (TFEB) is considered as a transcriptional regulator of autophagy-lysosome pathway such as lysosome biogenesis, as well as autophagosome-lysosome fusion (Sardiello et al. 2009; Settembre et al. 2012) . Under normal conditions, TFEB is localized to the cytoplasm but travels to the nucleus under starvation or when the lysosomal function is a need for compensation to activate its downstream target genes (Sardiello et al. 2009 ). The activity and nuclear translocation of TFEB are mainly controlled by mammalian target of rapamycin complex 1 (mTORC1), a kinase complex on the lysosomal surface that exerts its activity through binding to TFEB in the cytoplasm, while the deactivated mTORC1 leads to dephosphorylation of TFEB and consequently promoting TFEB nucleus translocation (Martina et al. 2012; Settembre et al. 2012) . Considering the importance of TFEB in regulating autophagy-lysosome pathway, the current study investigated the capacity of iron to promote a-synuclein aggregation and transmission by impairing autophagosome-lysosome fusion in a TFEB-dependent manner.
Materials and methods

Antibodies and reagents
The following antibodies and chemicals were used in this study: p62/SQSTM1 rabbit polyclonal antibody (Sigma, St Louis, MO, USA, P0067, RRID:AB_1841064), lysosomal-associated membrane protein 1 (LAMP1) rabbit polyclonal antibody (Abcam, Cambridge Science Park, Cambridge, UK, ab24170, RRID:AB_775978), (Sigma, 450936) , bafilomycin A1 (Baf A1; Selleck, S1413), LY294002 (Cell Signaling Technology, 9901), MK2206 (Selleck, S1078), Torin 1 (Selleck, S2827).
Cell culture and treatments SN4741, a mouse midbrain substantial nigra derived dopaminergic cell line (RRID:CVCL_S466) (Son et al. 1999) , was kindly provided by Dr Qian Yang (The Fourth Military Medical University, China). SN4741 cells were cultured in high glucose Dulbecco's modified Eagle's medium containing 10% fetal bovine serum (Invitrogen, Carlsbad, CA, USA), 1% penicillin-streptomycin, and 140 mM L-glutamine at 37°C in an incubator supplemented with 5% CO 2 . For experiments, cells were seeded at a density of 1 9 10 5 cells/cm 2 in flasks or plates.
Cell viability assay
Cell viability was measured using a Cell Counting Kit-8 (DOJINDO, Japan) according to the manufacturer's instructions. Construction of a a-synuclein transmission cell model An adenovirus vector expressing a-synuclein fused to red fluorescent protein (Ad-a-Syn-RFP), and vectors expressing either RFP (Ad-RFP) or green fluorescent protein (Ad-GFP) were constructed by HanBio Technology (China). Briefly, polymerase chain reaction (PCR) was performed on the plasmid to build a clone of RFP fused to human a-synuclein by a linker sequence. This template was then cloned into the pHBAd-U6-CMV vector using the SmaI restriction site. GFP or RFP alone was also cloned into the same vector. For adenovirus transduction, SN4741 cells were seeded in 12-well plates at a density of 2 9 10 5 per well and transduced with adenoviral particles according to the manufacturer's instructions. Pre-experiment optimization indicated the optimal multiplicity of infection was 500, which successfully transduced more than 90% of cells as indicated by fluorescence microscopy (data not shown). Cultured SN4741 cells were individually transfected with Ad-a-Syn-RFP, Ad-RFP or Ad-GFP adenoviral particles for 24 h, after which the culture medium was replaced with fresh medium and cells were cultured for an additional 24 h. After a total of 48 h in culture, transfected cells were harvested with trypsin and co-cultures of SN4741 cells expressing Ad-a-Syn-RFP or Ad-GFP were prepared in 12-well plates (density of 2 9 10 5 cells per well) at a ratio of 1 : 1 for an additional 1, 3 or 5 days of culture. As a control, SN4741 cells expressing either Ad-RFP or Ad-GFP fluorescent proteins were cocultured using the same conditions. Transmission of a-synuclein protein was confirmed by confocal microscopy and percentages of double-labeled cells were analyzed by flow cytometry.
Plasmid, siRNA and shRNA transfection The TFEB-GFP plasmid was constructed by cloning cDNA encoding the mouse TFEB gene into the CMV-MCS-EGFP-SV40-Neomycin vector using XhoI and KpnI restriction sites; empty vector was used as a control. The construct was confirmed by DNA sequencing. Both plasmids were transfected into SN4741 cells for 24 h using Lipofectamine 3000 reagent (Invitrogen) according to the manufacturer's instructions. For siRNA knockdown, siRNA targeting mouse TFEB (sequence: GCAGGCTGTCATGCATTAT) and a negative control were designed and synthesized by Ribobio Company (China). For transfection, SN4741 cells were seeded in 6-well plates at 30-40% confluence in antibiotic-free Opti-MEM reduced-serum medium. siRNA were transfected into SN4741 cells at a concentration of 50 nM using Lipofectamine 3000 reagent. After 24 h, knockdown efficacy was measured by real-time PCR (RT-PCR).
For shRNA knockdown, shRNA targeting mouse TFEB (sequence: CCGGATCAAGGAGCTGGGAAT) and a scrambled control (sequence: TTCTCCGAACGTGTCACGT) were constructed based on the lentiviral vector hU6-MCS-CMV-Puromycin and resulting lentiviral particles produced by Shanghai Genechem. Lentiviruses were transduced into SN4741 cells as previously described for selection of stable knockdown TFEB cell lines. TFEB knockdown was confirmed by western blot.
GFP-RFP-LC3 assay
To evaluate the late stage of autophagy, the tandem GFP-RFP-LC3 adenovirus was obtained from Hanbio Technology. Briefly, SN4741 cells were seeded in 12-well plates at a density of 2 9 10 5 cells per well and transduced with GFP-RFP-LC3 adenoviral particles at an multiplicity of infection of 500 according to the manufacturer's instructions. After 24 h of transfection, cells were treated according to the predefined experimental procedure and imaged by confocal microscopy (Leica Biosystems, Newcastle, UK) for counting of GFP and RFP puncta.
Rt-pcr
Total RNA was extracted from SN4741 cells after relevant treatment using Trizol reagent (Invitrogen) and converted to cDNA using PrimeScript TM RT Master Mix (RR036, Takara, Otsu, Japan) according to the manufacturer's instructions. RT-PCR was conducted in a fluorescent temperature cycler (ABI-Prism 7700 Sequence Detection System, Applied Biosystems, Foster City, CA, USA) using a Light Cycler FastStart DNA Master Plus SYBR Green kit (Roche Diagnostics GmbH). The following primers were used in this study: mouse TFEB forward 5ʹ-GACCTGACTCAGAAGCGAGAGCTA-3ʹ, and reverse, 5ʹ-GGATGGTGCCTTTGTTCCAG-3ʹ; mouse Lamp1 forward 5ʹ-TGGCACTGCAACTGAATATCACCTA-3ʹ, and reverse, 5ʹ-CACCA AGTTGATACCGCAACTCC-3ʹ; mouse Cat B forward 5ʹ-GCCCGA CCATTGGACAGATTAG-3ʹ, and reverse, 5ʹ-GGCCATTGGTGTG AATGCAG-3ʹ; mouse Cat D forward 5ʹ-GCAACAGAAGCTGGT GGACAA-3ʹ, and reverse, 5ʹ-CTTTCGAGTGACGTTCAGGTAG GA-3ʹ; mouse p62 forward 5ʹ-CCTTGCCCTACAGCTGAGTC-3ʹ, and reverse, 5ʹ-TGTTCCACATCAATGTCAACCTʹ; human a-synuclein forward 5ʹ-TGTGGCAGAAGCAGCAGGA-3ʹ, and reverse, 5ʹ-TGCCACACCATGCACCACT-3ʹ; mouse b-actin forward 5ʹ-TCCAG CCTTCCTTCTTGGGT-3ʹ, and reverse, 5ʹ-GCACTGTGTTGGCA TAGAGGT-3ʹ. Target gene mRNA levels were normalized to the level of b-actin and calculated using the 2 ÀΔΔCt method.
Protein extraction and western blot
For total protein extraction, treated cells were lysed in radioimmunoprecipitation assay buffer (Thermo, 89901) supplemented with protease and phosphatase inhibitor cocktail (Thermo, 78440), and then incubated on ice for 30 min. Cell lysates were sonicated and centrifuged at 12 000 g at 4°C for 20 min to obtain a supernatant. Alternatively, cytoplasmic and nuclear fractions were extracted using NE-PER TM nuclear and cytoplasmic extraction reagents (Thermo, 78835) according to the manufacturer's instructions. Triton-insoluble and -soluble fractions were extracted (Bae et al. 2014) by lysing treated cells on ice in extraction buffer containing 0.01 M phosphate-buffered saline, 1% Triton X-100, and a protease and phosphatase inhibitor cocktail. After incubation for 10 min, cell lysates were centrifuged at 16 000 g at 4°C for 10 min to obtain the soluble supernatant. The insoluble fraction was resuspended and sonicated in NuPAGE lithium dodecyl sulfate sample buffer (Invitrogen, NP0008). Protein concentrations were measured using a bicinchoninic acid protein assay (Thermo, 23225). Proteins were separated on a 12% sodium dodecyl sulfate polyacrylamide gel and transferred to polyvinylidene difluoride membranes (Millipore Corporation, Bedford, MA, USA). Alternatively, Triton-insoluble and -soluble fractions were separated on a 4-12% bis-tris protein gel (Invitrogen, NP0321BOX). Transferred membranes were blocked in tris-buffered saline containing 5% bovine serum albumin for 1 h at 25°C, and subsequently incubated with primary antibodies overnight at 4°C. After incubation, membranes were washed thrice with tris-buffered saline containing 0.1% Tween-20 and incubated with horseradish peroxidase-conjugated secondary antibodies for 1 h at 25°C. Bands were visualized by enhanced chemiluminescence (Millipore) using an ImageQuant LAS 4000 system (GE Healthcare, NJ, USA).
Enzyme-linked immunosorbent assay (ELISA)
Secreted a-synuclein proteins present in cell culture medium were measured using an ELISA method according to the manufacturer's instructions (Abcam, ab210973). Briefly, 50 lL of culture medium or standard were added to each well of a 96-well ELISA plate, and then 25 lL of 19 human a-synuclein capture antibody and 25 lL of 19 detector antibody were added to each well. After incubation for 1 h at 25°C on a shaker set to 400 rpm, plates were washed thrice with 19 wash buffer. After washing, 100 lL of 3,3 0 ,5,5-tetramethylbenzidine substrate was added to each well and the plate was incubated in the dark for 10 min on a shaker at 400 rpm. To stop the reaction, 100 lL of stop solution was added to each well and the plate was put back on the shaker for 1 min to mix. Optical density at 450 nm was measured.
Flow cytometry
For flow cytometry, co-cultured cells were treated with trypsin, resuspended in phosphate-buffered saline and then passed through a 40-lm filter to obtain a single suspension for CytoFLEX S flow cytometry analysis (Beckman). CytExpert software (Beckman) was used to analyze 2 9 10 4 cells per sample during each run.
Statistical analysis SPSS 21.0 software (IBM, San Jose, CA, USA) was used for statistical analysis. Data are expressed as the mean AE standard deviation (SD) and p < 0.05 was considered significant. Student's ttest was used for comparison of two groups, and one-way analysis of variance (ANOVA) was used for multi-group comparisons. All the data are available without any restriction. This study is not a clinical or animal study that not pre-registered, without using blinding or randomization, and not need institutional approval.
Results
Generation of a-synuclein transmission cell lines
To establish a stable and reliable a-synuclein transmission model, the mouse midbrain substantia nigra-derived dopaminergic cell line SN4741 was transduced with adenovirus vectors expressing a-synuclein fused to RFP fluorescent protein (Ad-a-Syn-RFP), or with vectors expressing either RFP (Ad-RFP) or GFP (Ad-GFP) fluorescent proteins for 48 h. After co-culturing SN4741 cells expressing either Ad-a-Syn-RFP or Ad-GFP for 1, 3 or 5 days, the transmission of a-synuclein protein was confirmed by confocal microscopy and percentage of double-labelled cells was analyzed by flow cytometry. Using confocal microscopy, we found that a-Syn-RFP protein could be transmitted to cells expressing Ad-GFP vectors, and we also confirmed that transmitted a-Syn-RFP protein was located inside the cell (rather than outside) by utilizing a two-dimensional imaging system ( Fig. 1) . A representative western blot analysis of Ad-a-Syn-RFP-transduced SN4741 cells is shown in Fig. 1d . After 24 h of co-culture, the proportion of double-labeled cells was 1.93%. With co-culture for 3 days, this proportion increased to 5.48%, however, the proportion of double-labeled cells did not significantly increase when co-culture time was extended to 5 days ( Fig. 2a and b) . As two earlier reports showed that fluorescent proteins could be transmitted between Neuro2a neuroblastoma cells, but such transmission appeared to be negligible in HEK293 and SH-SY5Y cell lines (Hansen et al. 2011; Reyes et al. 2015) , the transmission of fluorescent proteins may occur in a cell type-dependent manner. Thus, we explored whether RFP and GFP fluorescent proteins could be transferred in SN4741 cells. SN4741 cells expressing either Ad-RFP or Ad-GFP fluorescent proteins were co-cultured using the same conditions as above. After 1 day of co-culture, the proportion of double-labeled cells was 1.21%, and this proportion slightly increased to 1.96% with co-culture for 3 days. However, the proportion of double-labeled cells significantly increased to 3.90% after 5 days of co-culture ( Fig. 2c and d) . Thus, both a-synuclein fused to a fluorescent protein and fluorescent proteins alone can be transmitted cellto-cell. Although, the transmission ratio of a-synuclein fused to fluorescent protein was significantly higher than either fluorescent protein alone, especially at 3 days of co-culture. Hence, we chose 3 days of co-culture for subsequent transmission experiments.
Iron inhibits autophagosome-lysosome fusion As no previous research focused on iron in SN4741 cells, we first determined an appropriate FeCl 2 concentration for inducing iron accumulation. SN4741 cells were treated with different dosages of FeCl 2 (0, 100, 500, 1000, and 2000 lM) for 48 h. Dosages of 0, 100 and 500 lM FeCl 2 did not affect cell viability, while 1000 and 2000 lM FeCl 2 reduced cell viability (Fig. 3a) . As an endogenous expression of asynuclein is very low in SN4741 cells, we next transduced SN4741 cells with a lentiviral vector encoding human asynuclein; the efficacy of a-synuclein over-expression was verified by western blot (Fig. S1 ). Results of a western blot for 0, 100, and 500 lM FeCl 2 -treated SN4741 cells stably expressing a-synuclein for 48 h indicated that FeCl 2 increased a-synuclein expression in a dose-dependent manner (Fig. 3b) . We have also detected the mRNA levels of asynuclein, however, we did not find a significantly increase in a-synuclein mRNA levels after the treatment of 500 lM FeCl 2 (Fig. S2 ). This result is consistent with previous findings that have revealed that iron-induced a-syn aggregation was mainly regulated via a translational mechanism (Febbraro et al. 2012) . Thus, we used SN4741 cells treated with 500 lM FeCl 2 for 48 h in subsequent experiments.
Previous studies have shown that iron accumulation can lead to the impairment of lysosomal membrane integrity (Kurz et al. 2011; Terman and Kurz 2013) , which prompted us to investigate whether iron inhibits autophagosome-lysosome fusion. First, we examined levels of the lysosomal-associated membrane protein LAMP1. Western blot results showed that 500 lM FeCl 2 significantly decreased LAMP1 protein levels (Fig. 3c) . Next, we investigated whether FeCl 2 inhibited the fusion between autophagosomes and lysosomes using an mRFP-GFP tandem fluorescent-tagged LC3 (tfLC3), whereby GFP fluorescence was lost in acidic conditions but the mRFP signal not. Hence, puncta appeared yellow before the fusion of an autophagosome to the lysosome, but became red after this fusion because of the degradation of GFP fluorescence in acidic conditions (Kimura et al. 2007) . As shown in Fig. 3d , e, FeCl 2 treatment led to an obvious reduction in red puncta per cell. Moreover, in the presence of bafilomycin A1 (Baf A1), a vacuolar-type H + -ATPase inhibitor that restrains autophagosome-lysosome fusion (Yamamoto et al. 1998) , FeCl 2 treatment did not significantly alter the proportion of red puncta per cell, indicating an impairment of autophagosomelysosome fusion in FeCl 2 -treated SN4741 cells. On the other hand, the autophagosomes (yellow puncta) were significantly increased after the treatment of FeCl 2 (Fig. 3f) , whereas the increase was also not significantly observed in the presence of Baf A1. As the accumulation of autophagosomes reflects a decrease in lysosomal fusion capacity, thus the later data remains suggest an impairment of autophagosome-lysosome fusion after the treatment of FeCl 2 .
To strengthen this evidence, autophagosome-lysosome fusion substrates, such as polyubiquitin-binding protein p62 was measured. Effective fusion of an autophagosome to a lysosome resulted in a decrease in p62 levels (Bjorkoy et al. 2005) ; Western blot results showed that FeCl 2 treatment significantly increased protein levels of p62 (Fig. 3g) . However, FeCl 2 treatment did not significantly alter p62 levels in the presence of the autophagosome-lysosome fusion inhibitor Baf A1 (Fig. 3g) . Similar results were obtained in the absence of a-synuclein (Fig. S3) . These results further supported the impairment of autophagosomelysosome fusion in FeCl 2 -treated SN4741 cells. Moreover, since previous studies demonstrated p62 was a target gene of nuclear erythroid 2-related factor 2 (Nrf2) (Jain et al. 2010) , an anti-oxidant factor which can protect cells from oxidative stress induced by some electrophiles (Ishii et al. 1997; Nagaoka et al. 2004) , we then measured the levels of p62 mRNA after FeCl 2 treatment. We observed a rapid, transient increase in p62 mRNA after treated with 500 lM FeCl 2 for 1 h, then gradually decreased at 3 h, but did not observe any significant difference from 6 to 24 h (Fig. S4) . In addition to a transient increase in p62 mRNA level, the significantly increased level of p62 protein was obviously not due to increased transcription, which might represent a compensatory reaction in response to decreased Nrf2-p62 signal, as studies have shown that iron was associated with a down-regulation of Nrf2 (He et al. 2013; Inoue et al. 2017) . Taken together, these results indicate that the accumulation of p62 protein is probably because of the autophagosome-lysosome fusion deficiency that leads to prevention of p62 degradation.
Iron promotes a-synuclein aggregation and transmission by inhibiting autophagosome-lysosome fusion The autophagy-lysosome pathway plays a pivotal role in the degradation and propagation of aggregated a-synuclein (Pan et al. 2008; Alvarez-Erviti et al. 2011) , which prompts us to investigate whether iron promotes asynuclein aggregation and transmission by preventing autophagosome-lysosome fusion. As aggregated a-synuclein is insoluble in Triton, we measured Triton-soluble and Triton-insoluble a-synuclein fractions, as well as secreted a-synuclein present in culture medium 48 h after FeCl 2 -treatment of SN4741 cells stably expressing human a-synuclein. Western blot and ELISA results shown in Fig. 4 indicated that FeCl 2 treatment did not affect Tritonsoluble a-synuclein levels, while FeCl 2 treatment drastically increased Triton-insoluble a-synuclein levels and enhanced its secretion into the culture medium. However, FeCl 2 did not alter Triton-insoluble a-synuclein and secreted levels in the presence of the autophagosomelysosome fusion inhibitor Baf A1. Although treatment with either FeCl 2 or Baf A1 would lead to an increase in aggregated and secreted a-synuclein, the pretreatment with Baf A1 prior to FeCl 2 did not produce a cumulative effect, these results suggest that FeCl 2 promotes a-synuclein aggregation and secretion via inhibition of autophagosomelysosome fusion.
FeCl 2 treatment resulted in a reduction in a-synuclein degradation and an increase in a-synuclein secretion that strongly implicated an acceleration of a-synuclein transmission related to FeCl 2 treatment. As such, we next measured the proportion of a-synuclein cell-to-cell transmission using the transmission model generated above. Flow cytometry results (Fig. 5) showed that FeCl 2 treatment significantly increased the proportion of doublelabeled cells compared with the control group, but increased transmission of a-synuclein did not significantly vary in the presence of Baf A1; although, it should be noted that Baf A1 itself can cause an increased ratio of a-synuclein transmission (Fig. 5) . These results reveal that FeCl 2 promotes a-synuclein transmission via inhibition of autophagosome-lysosome fusion.
Iron promotes a-synuclein aggregation and transmission in a TFEB-dependent manner As autophagosome-lysosome fusion is transcriptionally mediated by TFEB (Settembre et al. 2012) , we investigated whether FeCl 2 promoted a-synuclein aggregation and transmission by regulating TFEB activity. To address this, we first examined TFEB mRNA and protein level after treatment with FeCl 2 . Surprisingly, we did not find a significant change in either mRNA or protein levels after FeCl 2 exposure ( Fig. 6a and b) . Given that the transcriptional activity of TFEB depends on its nuclear translocation, we separated nuclear and cytoplasmic fractions and found that FeCl 2 treatment obviously suppressed nuclear accumulation of TFEB and increased cytoplasmic TFEB levels (Fig. 6c) . Next, we examined the subcellular distribution of TFEB upon FeCl 2 treatment using confocal microscopy. SN4741 cells were transfected with a TFEB-GFP plasmid, and TFEB nuclear translocation was induced by the mechanistic target of rapamycin complex 1 inhibitor LY294002 (Martina et al. 2012) . Confocal microscopy indicated that FeCl 2 treatment significantly decreased TFEB nuclear fluorescence intensity compared with controls. Moreover, LY294002-induced TFEB nuclear translocation was obviously suppressed by pretreatment with FeCl 2 (Fig. 6d and e) . Meanwhile, the prevention of TFEB entering the nucleus following FeCl 2 treatment was associated with a down-regulation of mRNA and protein levels of TFEB target genes, such as lysosomalrelated genes LAMP1, Cat B and Cat D ( Fig. 6f and g;  Fig. 3c ). These results indicate that FeCl 2 inhibits TFEB nuclear translocation.
It has been reported that the activity and nuclear translocation of TFEB are mainly controlled by mammalian target of rapamycin complex 1 (mTORC1), a kinase complex on the lysosomal surface that exerts its activity through binding to TFEB in the cytoplasm, while the deactivated mTORC1 leads to dephosphorylation of TFEB and consequently promoting TFEB nucleus translocation (Martina et al. 2012; Settembre et al. 2012) . We, therefore, investigated whether iron inhibited TFEB nuclear translocation through activating Serine/Threonine Kinase (AKT)/mTORC1 signaling pathway, as AKT is upstream of target of the mTORC1 (Bhaskar and Hay 2007) . Western blot results showed that FeCl 2 treatment increased phosphorylation levels of AKT and the mTORC1 targets ribosomal protein S6 kinase (p70S6K) (Fig. 6h and i) . Furthermore results showed that the increased levels of Phospho-Akt were significantly inhibited by Akt inhibitor MK2206, meanwhile, the increased Phospho-p70S6K was also reversed by Torin-1, a canonical inhibitor of mTORC1 ( Fig. 6h and i) . These results show that iron-induced activation of the Akt/mTORC1 axis may be involved in preventing TFEB nuclear translocation.
As FeCl 2 treatment caused a loss of TFEB and prevented its nuclear translocation, this encouraged us to confirm whether TFEB was involved in FeCl 2 induced a-synuclein aggregation and transmission. First, to explore the relationship between TFEB and a-synuclein, as well as autophagosome-lysosome fusion substrate p62, we employed TFEB siRNA in SN4741 cells stably expressing human a-synuclein cells for 48 h. The silencing efficiency of TFEB reached a reduction in 85.5% as measured by RT-PCR. Western blot results demonstrated an elevation of total a-synuclein and p62 protein levels after TFEB knockdown (Fig. 5) , revealing that TFEB was an upstream target of autophagosomelysosome fusion. Furthermore western blot and ELISA results showed that TFEB siRNA significantly increased Triton-insoluble a-synuclein level and enhanced the secretion of a-synuclein into the culture medium compared with siRNA control (Fig. 7) . In addition, both TFEB siRNA and controls consistently increased either Triton-insoluble or secreted a-synuclein level in the presence of FeCl 2 treatment, but these levels did not differ after silencing TFEB between the presence or absence of FeCl 2 (Fig. 7) . These results indicate that FeCl 2 -induced a-synuclein aggregation and secretion is mediated by TFEB.
Next, we explored the proportion of transmitted asynuclein after silencing TFEB in the absence or presence of FeCl 2 . SN4741 cell lines stably expressing either TFEB shRNA or negative control were constructed using a lentiviral vector expressing mouse TFEB shRNA or scrambled sequence, respectively. Western blot results indicated that TFEB protein levels in cell lines stably expressing TFEB shRNA was greatly decreased compared with the negative control (Fig. S6) . Next, SN4741 cells stably expressing TFEB shRNA or scrambled sequence was transduced with vectors expressing Ad-a-Syn-RFP or Ad-GFP to generate a asynuclein transmission model, as previously described. Flow cytometry results (Fig. 8) indicated that silencing TFEB gene by lentivirus-delivered shRNA obviously enhanced the proportion of double-labeled cells in the absence of FeCl 2 compared with the negative shRNA control group. However, the transmission ratio of a-synuclein did not significantly differ between these groups in the presence of FeCl 2 (Fig. 8) .
Furthermore, we also measured the proportion of transmitted a-synuclein when over-expressing TFEB in the presence or absence of FeCl 2 . Firstly, we checked whether TFEB over-expression was effective in reducing a-synuclein expression and promoting p62 degradation. We transduced SN4741 cells stably expressing human a-synuclein with a TFEB plasmid or vector and the TFEB mRNA level was upregulated 2.1 times as measured by RT-PCR. Western blot results demonstrated a decrease in total a-synuclein and p62 protein levels after TFEB over-expression, further indicating that TFEB was an upstream target of autophagosomelysosome fusion. Secondary, we transduced SN4741 cells with a lentiviral vector encoding TFEB, the efficacy of TFEB over-expression was verified by western blot (Fig. S7) . Thereafter, SN4741 cells stably over-expressing TFEB or vector were used to generate a a-synuclein transmission model, as previously described. Flow cytometry results (Fig. 9) showed that TFEB over-expressing lead to a proportion reduction in double-labeled cells from 5.5% of the vector group to 4.5%. Moreover, FeCl 2 induced asynuclein transmission was reversed by over-expressing TFEB (Fig. 9) . These results suggest that TFEB may be a potential target for preventing the transmission of asynuclein, and support the notion that FeCl 2 promotes asynuclein transmission in a TFEB-dependent manner.
Discussion
Recent studies have demonstrated that many neuropathogenic proteins involved in non-infectious neurodegenerative diseases exhibit propagation features similar to prionopathies (Frost and Diamond 2010) . Nevertheless, underlying causes and mechanisms of aggregated proteins spreading between neurons, and whether similar propagation mechanisms are shared between non-prion and prion proteins remains to be elucidated. We noted a common phenomenon Representative western blot analysis of total, cytoplasmic, and nuclear protein levels of TFEB after treated with 500 lM FeCl 2 for 48 h. (d and e) After 24 h transfection of TFEB-GFP plasmid, SN4741 cells were incubated with the following treatments for 2 h: (1) 500 lM FeCl 2 ; (2) LY294002, an inducer of TFEB nuclear translocation; (3) pretreated with 10 lM LY294002 in 30 min prior to 500 lM FeCl 2 . TFEB nuclear fluorescence intensities of representative confocal microscopy pictures was analyzed using Image J software and expressed as percentage of total fluorescence intensity, 10 cells were analyzed per experiment.
Scale bar: 10 lm. (f) Relative mRNA levels of TFEB target genes LAMP1, Cat B and Cat D were measured after SN4741 cells were treated with 500 lM FeCl 2 for 6 h. (g) Representative western blot analysis of Cat B, Cat D after treated with 500 lM FeCl 2 for 48 h. (h and i) SN4741 cells were incubated with the following treatments for 15 min: (1) 500 lM FeCl 2 ; (2) 1 lM MK2206, an inhibitor of Akt signaling; (3) pretreated with 1 lM MK2206 in 15 min prior to 500 lM FeCl 2 ; (4) 100 nM Torin-1, an inhibitor of mTORC1 signaling; (5) pretreated with 100 nM Torin-1 in 15 min prior to 500 lM FeCl 2 , then the protein levels AKT, pAKT, mTORC1 targets p70S6K and pp70S6K were measured. Data are presented as means AE SD from three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001.
between transmissible neuropathogenic and prion proteins: iron accumulation (Singh et al. 2009 Oshiro et al. 2011; Muller and Leavitt 2014; Singh 2014; Belaidi and Bush 2016; Gajowiak et al. 2016) . We speculated that iron accumulation might be a common contributing factor promoting propagation of neuropathogenic and prion proteins. As a-synuclein protein is most easily transmitted (Ugalde et al. 2016 ) and iron accumulation is particularly prominent in synucleinopathies (Snyder and Connor 2009; Jiang et al. 2016) , we investigated the relationship between iron and a-synuclein transmission. Here, we found that iron promoted a-synuclein aggregation and transmission by inhibiting autophagosome-lysosome fusion in a TFEBdependent manner. Moreover, we identified TFEB as a potential target for preventing the transmission of asynuclein.
Although cell-to-cell transmission of misfolded proteins is well established in both animal models and human studies (Guo and Lee 2014) , few cell models permit further investigation of propagation mechanisms for misfolded proteins. In this study, we constructed a cell-to-cell transmission model of a-synuclein using a mouse midbrain substantia nigra-derived dopaminergic cell line (Son et al. 1999) , which better reflected the characteristics of dopaminergic neurons than cell lines used in previous works (Hansen et al. 2011; Reyes et al. 2015) . In this model, we observed that both a-synuclein and fluorescent proteins could be transmitted between cells, but a-synuclein showed a higher ratio of transmission than fluorescent proteins alone, indicating transmission of a-synuclein was independent of fluorescent protein fusion. Considering that the construction of a-synuclein transmission model was based on adenoviral particles, the cells were adequately washed to avoid the residual virus. Unlike other vectors, the adenoviral vector does not insert its DNA to the chromosome and lacks the ability of self-replication, its effect is transient and will not affect the cell's normal function (Bett et al. 1993; Xiang et al. 1996; Massie et al. 1998) . Thus, when the adenoviral vector was transported to target SN4741 cells, it was unlikely to interfere with the surrounding cells. In addition, the relatively low percentage of baseline double-labeled cells and subsequent small changes in a variety of different treatment conditions may be due to the following reasons. Firstly, the cell proliferation causes a dilution of the double-labeled cells; secondary, some double-labeled cells might actually not be detected by flow cytometry as their transferred protein may be cleared through a cell-autonomous regulation mechanism. Nevertheless, the baseline percentage of double-labeled cells in our model was significantly higher than other models (Hansen et al. 2011; Reyes et al. 2015) . Furthermore, cells co-cultured for 3 days exhibited the highest amounts of double-labeled cells. While the optimal co-culture time for our model was earlier than other models (Hansen et al. 2011; Reyes et al. 2015) , these differences may arise from the use of different cell lines and adenovirus vectors in this study. Adenovirus expressing a-Syn-RFP may result in rapidly increasing and maintaining high expression levels of a-Syn-RFP that gradually decrease over time, as higher expression levels of a-synuclein lead to a higher ratio of the transmission (Devine et al. 2011) . This reasonably explains why the proportion of transferred a-synuclein did not increase after the third day of co-culture in our model. Our data suggest that a transmission model based on adenovirus vectors is suitable for detecting the ratio of transferred a-synuclein using flow cytometry at earlier time points. It should be noted that methods employed to measure the transmission of asynuclein mainly rely upon fluorescence intensity, making them difficult to directly quantify levels of transmitted asynuclein. Therefore, improved approaches to accurately quantify transferred a-synuclein are needed in the future.
While previous work has focused on the role of iron in the aggregation of a-synuclein through mechanisms of oxidative stress (Ostrerova-Golts et al. 2000; Belaidi and Bush 2016) , this only partially causes iron-induced a-synuclein aggregation (He et al. 2011; Li et al. 2011) , suggesting that other unexplored mechanisms are involved. Generally, the autophagy-lysosome pathway is the major pathway for degradation of aggregated a-synuclein (Pan et al. 2008) . The autophagy-lysosome process includes two stages: during the early stage, the phagophore or isolation membrane wraps around cytoplasmic constituents to form autophagosomes, but no material degradation occurs; during the late stage, the autophagosome fuses to the lysosome to form an autolysosome and constituents contained within the autophagosome are degraded (Mizushima 2007) . As iron accumulation leads to impairment of lysosomal membrane integrity (Kurz et al. 2011; Terman and Kurz 2013) we investigated the role of autophagosome-lysosome fusion in the process of ironinduced a-synuclein aggregation. As expected, our data suggest that iron promotes a-synuclein aggregation by impairing the late stage of the autophagy-lysosome pathway, consistent with newly published work showing autophagic dysfunction at the initial stage after treatment of SH-SY5Y cells with iron (Wan et al. 2017) .
The underlying mechanisms of a-synuclein transfer between dopaminergic neurons are still poorly understood, although lysosomal dysfunction has been shown to play a pivotal role (Alvarez-Erviti et al. 2011; Bae et al. 2014 Bae et al. , 2015 Abounit et al. 2016) . In this study, we found that Baf A1, an inhibitor of fusion between autophagosomes and lysosomes (Yamamoto et al. 1998) , leads to increased aggregation, secretion, and transmission of a-synuclein. Furthermore, we observed that iron promoted a-synuclein secretion and transmission, but this effect was not altered by the presence of Baf A1, indicating iron-induced a-synuclein secretion and transmission arose from the impairment of autophagosome-lysosome fusion. Although the precise molecular mechanisms on how did iron facilitate the spread of a-synuclein were not well addressed, it was speculated that iron leads to TFEB-mediated lysosomal dysfunction, which promotes a-synuclein release via packaging into exosomes (Alvarez-Erviti et al. 2011), then the released exosomes could be taken up by neighboring cells. As we know, exosomal transport is one of the most important pathways that participate in regulating the transmission of asynuclein from cell-to-cell (Danzer et al. 2012; Emmanouilidou and Vekrellis 2016) . However, the precise contribution of the exosome in this pathway requires further investigation.
TFEB, a master transcriptional regulator of autophagosome-lysosome fusion (Settembre et al. 2012) , has shown a promising effect for preventing a-synuclein-induced toxicity (Decressac et al. 2013) . Therefore, we explored whether TFEB was involved in iron-induced a-synuclein aggregation, secretion, and transmission. TFEB transcriptional activity depends on its nuclear translocation -we found that iron decreased nuclear level of TFEB and inhibited TFEB nuclear translocation through activating AKT/mTORC1 signaling pathway. After silencing the TFEB gene, aggregation, secretion, and transmission of a-synuclein were obviously enhanced. While this result was similar to treatment with iron, increased aggregation, secretion, and transmission of asynuclein resulting from TFEB silencing were not significantly altered in the presence of iron. Moreover, the ironinduced a-synuclein transmission was reversed by overexpressing TFEB. Taken together, these results suggest that TFEB is not only a potential target for preventing the transmission of a-synuclein but also a critical factor for ironinduced a-synuclein aggregation and secretion.
As previously described, we suspected that iron accumulation might be a common contributing factor promoting propagation of neuropathogenic and prion proteins. Indeed, we concluded that iron promoted a-synuclein cell-to-cell transmission in a TFEB-dependent manner. Although we did not investigate transmission mechanisms between iron and other neuropathogenic proteins directly, similar processes of iron deposition (Oshiro et al. 2011; Muller and Leavitt 2014; Belaidi and Bush 2016; Gajowiak et al. 2016 ) and lysosomal dysfunction (Boyd and Valenzano 2014; Fraldi et al. 2016) in neurodegenerative disorders lead us to believe that iron might be a shared factor participating in the transfer of other neuropathogenic proteins.
In conclusion, we find that our model based on adenovirus vectors is suitable for detecting the ratio of cell-to-cell transmitted a-synuclein using flow cytometry. Our data indicate that iron promotes a-synuclein aggregation and cellto-cell transmission by inhibiting TFEB-mediated autophagosome-lysosome fusion, revealing a previously unknown relationship between iron and a-synuclein. We also identify TFEB as a potential target for preventing the transmission of asynuclein and its critical role for iron-induced a-synuclein aggregation and secretion, in addition to transmission. Overall, these results imply that inhibiting iron accumulation and promoting TFEB nuclear translocation may provide novel targets for reducing intercellular transmission of a-synuclein. 
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